NAMOXYRATE

Details

Stereochemistry	RACEMIC
Molecular Formula	C16H16O2.C4H11NO
Molecular Weight	329.4333
Optical Activity	( + / - )
Defined Stereocenters	0 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CN(C)CCO.CCC(C(O)=O)C1=CC=C(C=C1)C2=CC=CC=C2

InChI

InChIKey=SNUBSRMFCPAKSI-UHFFFAOYSA-N

InChI=1S/C16H16O2.C4H11NO/c1-2-15(16(17)18)14-10-8-13(9-11-14)12-6-4-3-5-7-12;1-5(2)3-4-6/h3-11,15H,2H2,1H3,(H,17,18);6H,3-4H2,1-2H3

HIDE SMILES / InChI

Description
Sources: https://www.genome.jp/dbget-bin/www_bget?drug:D06337

Xenbucin is an antihyperlipidemic agent. Information about the current use of this agent is not available.

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
acetylcholine biosynthetic process 7 Target ID: GO:0008292 Sources: https://www.ncbi.nlm.nih.gov/pubmed/13537882	Inhibitor 8504

Name

Type

Language

W 1760A

Preferred Name

English

NAMOXYRATE

Official Name

English

?-Ethyl-4-biphenylacetic acid, compound with 2-dimethylaminoethanol (1:1)

Common Name

English

NAMOL XENYRATE

Common Name

English

W-1769A

Code

English

W-1760A

Code

English

NAMOXYRATE [USAN]

Common Name

English

(1,1'-BIPHENYL)-4-ACETIC ACID, .ALPHA.-ETHYL-, COMPD. WITH 2-(DIMETHYLAMINO)ETHANOL (1:1)

Common Name

English

XENBUCIN DEANOL

Common Name

English

namoxyrate [INN]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C257